Atricure Stock Investor Sentiment

ATRC Stock  USD 36.01  0.27  0.76%   
About 59% of AtriCure's investor base is looking to short. The analysis of overall sentiment of trading AtriCure stock suggests that many investors are alarmed at this time. The current market sentiment, together with AtriCure's historical and current headlines, can help investors time the market. In addition, many technical investors use AtriCure stock news signals to limit their universe of possible portfolio assets.
  

AtriCure Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards AtriCure can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over two weeks ago at simplywall.st         
A Piece Of The Puzzle Missing From AtriCure, Inc.s 28 percent Share Price Climb
Simply Wall St News at Macroaxis
over two weeks ago at gurufocus.com         
AtriCure Inc Shares Up 3.58 percent on Nov 5
Gurufocus Stories at Macroaxis
over two weeks ago at gurufocus.com         
AtriCure Stock Surges Over 5 percent Amid Market Volatility
Gurufocus Stories at Macroaxis
over three weeks ago at thelincolnianonline.com         
Canaccord Genuity Group Forecasts Strong Price Appreciation for AtriCure Stock
news
over three weeks ago at simplywall.st         
US42.67 - Thats What Analysts Think AtriCure, Inc. Is Worth After These Results
Simply Wall St News at Macroaxis
over three weeks ago at finance.yahoo.com         
US42.67 - Thats What Analysts Think AtriCure, Inc. Is Worth After These Results
Yahoo News
over three weeks ago at simplywall.st         
Is It Time To Consider Buying AtriCure, Inc.?
Simply Wall St News at Macroaxis
over three weeks ago at thelincolnianonline.com         
AtriCure, Inc. Sees Significant Decline in Short Interest
news
over three weeks ago at thelincolnianonline.com         
AtriCure Posts Earnings Results
news
over three weeks ago at insidermonkey.com         
AtriCure, Inc. Q3 2024 Earnings Call Transcript
insidermonkey News
over three weeks ago at investors.com         
AtriCure Hits 80-Plus Relative Strength Rating Benchmark
Investors Business Daily at Macroaxis
over three weeks ago at gurufocus.com         
AtriCure Inc Shares Up 21.47 percent on Oct 30
Gurufocus Stories at Macroaxis
over three weeks ago at massdevice.com         
AtriCure plans a surgical pulsed field ablation play
news
over three weeks ago at investing.com         
Earnings call AtriCure reports robust growth, raises full-year guidance
Investing News at Macroaxis
over three weeks ago at gurufocus.com         
AtriCure Inc Q3 2024 Earnings Call Highlights Strong Revenue Growth Amidst Market Challenges
Gurufocus Stories at Macroaxis
Far too much social signal, news, headlines, and media speculation about AtriCure that are available to investors today. That information is available publicly through AtriCure media outlets and privately through word of mouth or via AtriCure internal channels. However, regardless of the origin, that massive amount of AtriCure data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of AtriCure news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of AtriCure relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to AtriCure's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive AtriCure alpha.

AtriCure Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Is It Time To Consider Buying AtriCure, Inc.
09/16/2024
2
AtriCure Announces Launch of cryoSPHERE MAX Probe for Post-Operative Pain Management
10/15/2024
3
AtriCure plans a surgical pulsed field ablation play
10/30/2024
4
AtriCure Hits 80-Plus Relative Strength Rating Benchmark
10/31/2024
5
A Piece Of The Puzzle Missing From AtriCure, Inc.s 28 percent Share Price Climb
11/06/2024
6
AtriCure to Participate in the Stifel 2024 Healthcare Conference
11/07/2024
7
Spolenost VentureOne ze skupiny ATRC pedstavuje na veletrhu CyberQ projekt QuantumGate pro zabezpeen dat pro kvantovou ru
11/14/2024
8
Disposition of 4417 shares by Dahlquist Karl S. of AtriCure at 44.83 subject to Rule 16b-3
11/15/2024
9
AtriCure to Participate in the Piper Sandler 36th Annual Healthcare Conference
11/20/2024

Complementary Tools for AtriCure Stock analysis

When running AtriCure's price analysis, check to measure AtriCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AtriCure is operating at the current time. Most of AtriCure's value examination focuses on studying past and present price action to predict the probability of AtriCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AtriCure's price. Additionally, you may evaluate how the addition of AtriCure to your portfolios can decrease your overall portfolio volatility.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Stocks Directory
Find actively traded stocks across global markets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance